Results from a late-stage clinical trial are expected in December of this year and, if positive, could reignite Novo shares.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Weight loss drugs like semaglutide may reduce knee pain from osteoarthritis offering a promising alternative to knee ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Researchers have discovered that semaglutide weight loss drugs like Ozempic may reduce the risk of early-onset colorectal cancer (CRC) in diabetes patients.

US Black and Hispanic populations are, on average, more prone to obesity and related ... The UK National Health Service ...

participants gained most of their lost weight back after stopping semaglutide for a year. These people regained an average of ...